晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02228 晶泰控股

未开盘 02-25 16:08:35

10.510

-0.150

-1.41%

最高10.770	最低10.460	成交量4,248万
今开10.550	昨收10.660	日振幅2.91%
总市值452.25亿	流通市值452.25亿	总股本43.03亿
成交额4.50亿	换手率0.99%	流通股本43.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":10.51,"timestamp":1772006915004,"preClose":10.66,"halted":0,"volume":42480727,"delay":0,"changeRate":-0.01407129455909947,"floatShares":4303000000,"shares":4303000000,"eps":-0.9013982169390787,"marketStatus":"未开盘","change":-0.15,"latestTime":"02-25 16:08:35","open":10.55,"high":10.77,"low":10.46,"amount":449579044,"amplitude":0.029081,"askPrice":10.52,"askSize":20000,"bidPrice":10.51,"bidSize":58000,"shortable":3,"etf":0,"ttmEps":-0.05705052005943537,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772069400000},"marketStatusCode":0,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":10.66,"openAndCloseTimeList":[[1771983000000,1771992000000],[1771995600000,1772006400000]],"volumeRatio":1.065869257973833,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02228/tweets","defaultTab":"tweets","newsList":[{"id":"2613357027","title":"每日卖空追踪 | 晶泰控股 02月23日卖空量成交142.2万股，卖空比例为8.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613357027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613357027?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835428,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间02月23日，涨0.09%，卖空量成交142.2万股，较上一交易日减少66.68%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163330a4be7d58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163330a4be7d58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2613735058","title":"晶泰控股02月23日获主力加仓212.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613735058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613735058?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:15","pubTimestamp":1771834524,"startTime":"0","endTime":"0","summary":"02月23日, 晶泰控股股价涨0.09%，报收11.26元，成交金额1.9亿元，换手率0.39%，振幅2.58%，量比0.48。晶泰控股今日主力资金净流入212.9万元，上一交易日主力净流入286.0万元。该股近5个交易日下跌0.62%，主力资金累计净流出4370.3万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1.3亿元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161624a4be70dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161624a4be70dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2612625396","title":"超600倍的安全窗口 晶泰(02228)赋能默达生物开发全球首个口服LDH抑制剂获关键进展 剑指千亿美元自免市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2612625396","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612625396?lang=zh_cn&edition=full","pubTime":"2026-02-20 11:15","pubTimestamp":1771557330,"startTime":"0","endTime":"0","summary":"MP-5342是晶泰科技赋能默达生物开发的全球首款口服小分子乳酸脱氢酶抑制剂。MP-5342是晶泰科技与默达生物合作研发的第二条即将进入临床开发的首创新药管线。MP-5342是晶泰科技基于其AI+机器人药物发现平台与默达生物合作开发的口服LDH抑制剂。此前，晶泰科技与默达生物合作开发了全球首创的针对原发性高草酸尿症的小分子抑制剂META-001-PH，已获得FDA 孤儿药资格认定和儿童罕见病资格认定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"超600倍的安全窗口 晶泰(02228)赋能默达生物开发全球首个口服LDH抑制剂获关键进展 剑指千亿美元自免市场","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2611953134","title":"每日卖空追踪 | 晶泰控股 02月13日卖空量成交344.1万股，卖空比例为7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611953134","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611953134?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971430,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间02月13日，涨0.45%，卖空量成交344.1万股，较上一交易日减少40.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163412a6f6e555&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163412a6f6e555&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1617","BK1141"],"gpt_icon":0},{"id":"2610969486","title":"创新药概念震荡反弹 高增长潜力概念股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2610969486","media":"腾讯自选股综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610969486?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:17","pubTimestamp":1770693474,"startTime":"0","endTime":"0","summary":"创新药概念盘中震荡反弹，广生堂涨超10%，此前万邦德涨停，尖峰集团、信立泰、北陆药业、荣昌生物、首药控股等多股涨超5%。华源证券指出，经历短期波动消化后，创新药板块已显现企稳回暖迹象。整体上，国金证券认为创新药前期回调较为充分，向上产业趋势明确，催化近期密集，继续看好板块投资机会。从未来增长潜力来看，多股获机构预测2026年净利增速有望翻倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","02196","00013","01548","BK1161","02096","01276","01877","BK1574","06978","02269","01177","01093","02228","03692","BK1583","01952","01513","BK1515","00512","06185","06160","01801"],"gpt_icon":0},{"id":"2610685692","title":"晶泰控股盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610685692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610685692?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:50","pubTimestamp":1770688237,"startTime":"0","endTime":"0","summary":"2026年02月10日早盘09时50分，晶泰控股股票出现波动，股价快速上涨5.14%。截至发稿，该股报11.870港元/股，成交量1889.4万股，换手率0.44%，振幅3.99%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。晶泰控股股票所在的生物技术行业中，整体涨幅为0.08%。晶泰控股公司简介：晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210095037a4914471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210095037a4914471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2610307236","title":"晶泰控股(02228)：晶泰科技机器人实验室落地巴斯夫 全球技术领导力获化工业顶级背书","url":"https://stock-news.laohu8.com/highlight/detail?id=2610307236","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610307236?lang=zh_cn&edition=full","pubTime":"2026-02-09 20:41","pubTimestamp":1770640888,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股 发布公告，近日，本集团已成功向全球化工巨头巴斯夫交付了一种配方稳定性测试自动化工作站，助力巴斯夫构建起“样品管理-测试分析-数据管理”全链路的自动化体系。巴斯夫是全球化工行业的领导者，业务横跨化学品、材料、工业解决方案以及营养与护理等业务领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403342.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股(02228)：晶泰科技机器人实验室落地巴斯夫 全球技术领导力获化工业顶级背书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK1141","BK1617"],"gpt_icon":1},{"id":"2610635046","title":"每日卖空追踪 | 晶泰控股 02月09日卖空量成交483.7万股，卖空比例为10.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610635046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610635046?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625829,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间02月09日，涨0.09%，卖空量成交483.7万股，较上一交易日减少41.65%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163811a6e5502d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163811a6e5502d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2610150494","title":"晶泰科技首席执行官马健：深圳科技企业需锚定AI for Science发展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2610150494","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610150494?lang=zh_cn&edition=full","pubTime":"2026-02-09 09:58","pubTimestamp":1770602329,"startTime":"0","endTime":"0","summary":"人民财讯2月9日电，2月9日上午，深圳市七届人大七次会议举行首场“代表通道”集体采访。深圳市人大代表，晶泰科技联合创始人、首席执行官马健在采访中提到，深圳科技企业要实现从技术领先到产业引领的跨越，需锚定AIforScience发展方向，立足创新生态优势，做好三个“聚焦”，包括聚焦生态协同，聚焦价值落地和聚焦生态培育。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602093645127737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02228","BK1617","167506","BK1141"],"gpt_icon":0},{"id":"2610663507","title":"医药生物行业跟踪周报：分子胶海外风起 国内管线蓄势破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2610663507","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610663507?lang=zh_cn&edition=full","pubTime":"2026-02-09 00:00","pubTimestamp":1770566400,"startTime":"0","endTime":"0","summary":"分子胶海外风起，已经诞生RVMD、GLU、KYMR 等多个大牛股，并且已经诞生多个重大BD，国内企业已有较多布局，但是关注度较低，存在较大认知差。奥赛康BD 引进ANL pan-RAS 分子胶的中国权益，预计26Q1 开展1 期临床；达歌生物已经与武田、默沙东建立合作，拥有两款FIC 分子胶，DAC 亦有布局。我们认为，分子胶有望在肿瘤及自身免疫病等广阔市场中催生出新一代重磅炸弹级药物，建议重点关注国内布局企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209170638a48e7ce6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209170638a48e7ce6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023057109.AUD","01276","LU0359201612.USD","LU2543165471.USD","02228","09606","BK1191","LU0359201885.HKD","LU0359202008.SGD"],"gpt_icon":0},{"id":"2609596077","title":"每日卖空追踪 | 晶泰控股 02月06日卖空量成交462.9万股，卖空比例为12.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609596077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609596077?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366630,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间02月06日，股价较前一交易日持平，卖空量成交462.9万股，较上一交易日减少18.19%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163442a483cf25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163442a483cf25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141","BK1617"],"gpt_icon":0},{"id":"2609998345","title":"晶泰控股02月06日主力净流出428.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2609998345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609998345?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:16","pubTimestamp":1770365760,"startTime":"0","endTime":"0","summary":"02月06日，晶泰控股股价收平报11.28元，成交金额4.3亿元，换手率0.89%，振幅4.61%，量比0.69。晶泰控股今日主力资金净流出428.9万元，上一交易日主力净流入552.3万元。该股近5个交易日下跌6.21%，主力资金累计净流出225.7万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1.1亿元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206162222a6dab358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206162222a6dab358&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141","BK1617"],"gpt_icon":0},{"id":"2609379056","title":"纽曼思(02530)：购入300万股晶泰科技股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2609379056","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609379056?lang=zh_cn&edition=full","pubTime":"2026-02-05 19:28","pubTimestamp":1770290927,"startTime":"0","endTime":"0","summary":"智通财经APP讯，纽曼思(02530)发布公告，于2026年2月5日，集团于公开市场以总代价约3380万港元(包括印花税及相关开支)购入总共300万股晶泰科技股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","02530","BK1207","BK1141","BK1617"],"gpt_icon":0},{"id":"2609058472","title":"维升药业深化源头创新布局携手晶泰科技以AI赋能内分泌新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2609058472","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609058472?lang=zh_cn&edition=full","pubTime":"2026-02-05 18:41","pubTimestamp":1770288060,"startTime":"0","endTime":"0","summary":"2026年2月5日，维升药业与晶泰科技宣布达成项目协议及长期战略合作，合作规模达数千万元。维升药业旨在将晶泰科技AI技术深度整合至内分泌新药源头创新，聚焦高临床价值适应症与创新靶点，加速构建产品管线。此次合作是其在夯实内部研发、引进成熟管线基础上的精准布局，通过AI驱动突破传统研发瓶颈，为产品管线注入新动能。维升药业已构建全链条布局，认识到持续引领创新需挖掘新靶点、拓展适应症、迭代升级管线。内分泌代谢疾病机制复杂，传统研发模式挑战大，维升药业引入晶泰科技AI药物发现平台，双方合作将聚焦内分泌代谢领域，实现候选新分子早期发现和优化设计，系统性降低后续研发风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205190546a6d6ed2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205190546a6d6ed2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1141","BK1617","02228","BK1161"],"gpt_icon":0},{"id":"1169719075","title":"晶泰控股（02228）2026年1月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1169719075","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169719075?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:38","pubTimestamp":1770280701,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司于2026年2月5日公布截至2026年1月31日的股份变动月报表。根据公告，报告期内公司法定股本维持在合计USD 1,000,000，已发行普通股数量保持为4,303,371,761股，未出现新增发行、购回或注销股份的情况。公司本月未发生任何库藏股变化或回购事项，整体股本结构保持稳定。公告最后，公司确认截至2026年1月末符合香港联交所的最低公众持股要求，并持续遵守相关上市规则。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"gpt_icon":0},{"id":"2609391588","title":"晶泰控股02月04日遭主力抛售500.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609391588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609391588?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192934,"startTime":"0","endTime":"0","summary":"02月04日, 晶泰控股股价跌2.40%，报收11.38元，成交金额5.6亿元，换手率1.15%，振幅4.03%，量比0.75。晶泰控股今日主力资金净流出500.1万元，上一交易日主力净流出422.0万元。该股近5个交易日下跌8.45%，主力资金累计净流出3268.6万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入2.5亿元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161800a47afae0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161800a47afae0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2608935539","title":"晶泰科技与晶科能源合作模式获马斯克团队青睐，AI+太空光伏或成\"AI for Science, Science for AI\"典范应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2608935539","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608935539?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:47","pubTimestamp":1770191222,"startTime":"0","endTime":"0","summary":"据业内消息，上周，马斯克团队对中国光伏产业链进行了调研，对象包括TCL中环、晶科能源、晶盛机电等企业。晶泰与晶科的合作，正是\"AI for Science\"与\"Science for AI\"理念在现实场景中的完美闭环与落地示范。　　据悉，双方将有多位高管在合资公司中担任要职，晶泰科技团队成员将出任首席科学家职位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9a93afba3df83790eeb050081600dc3b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260204/31997648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4099","LU1366192091.USD","LU1066053197.SGD","LU1861558580.USD","SG9999015952.SGD","LU0345769128.USD","BK4519","IE00BK4W5M84.HKD","LU2896262040.SGD","LU2456880835.USD","LU1429558221.USD","LU0077335932.USD","LU2756315664.SGD","LU2108987350.USD","LU0708995401.HKD","LU1066051498.USD","TSLP","LU0348723411.USD","BK4555","LU2290526834.HKD","02228","LU2023250330.USD","LU0082616367.USD","LU0823411888.USD","LU0672654240.SGD","LU0316494557.USD","LU2756315318.SGD","BK4548","TSLL","TSLW","LU1720051017.SGD","IE00B19Z8X17.USD","LU2063271972.USD","LU0345770993.USD","LU2471134879.HKD","TSLG","LU1839511570.USD","SG9999015945.SGD","TSLQ","TSL","BK4581","LU1861215975.USD","BK4516","BK1617","LU2750360997.AUD","LU1629891620.HKD","LU1435385759.SGD","LU0320765059.SGD","LU0943347566.SGD","LU0198837287.USD","LU2213496289.HKD","TSLS","LU2420271590.USD","LU0689472784.USD","BK4551","LU2236285917.USD","BK4534","LU1066051811.HKD","LU1551013342.USD","LU2602419157.SGD","BK4141","LU2087621335.USD","LU2326559502.SGD","LU2471134952.CNY","TSLT","LU2403377893.USD","BK4550","LU1720051108.HKD","LU1861559042.SGD","LU0820561818.USD","LU0210536198.USD","LU0964807845.USD","LU1674673428.USD","LU2357305700.SGD","LU0719512351.SGD","TSLZ","TSII","BK4598","LU0345769631.USD","LU1861220033.SGD","07766","LU0323591593.USD","LU1267930730.SGD","TSYY","BK4612","LU0820562030.AUD","BK4527","SG9999015978.USD","SG9999015986.USD","LU2360107168.USD","IE00B19Z9505.USD","TESL","LU0109391861.USD","LU1232071149.USD","LU0345770308.USD","JKS","LU2250418816.HKD","BK4604","LU0234570918.USD","LU1548497426.USD","BK4588","BK4543","LU0053666078.USD","IE00B1XK9C88.USD","CRSH","LU1852331112.SGD","LU2462157665.USD","LU2360106780.USD","BK4574","LU2417539215.USD","LU2249611893.SGD","IE00BJLML261.HKD","LU0466842654.USD","IE0034235303.USD","LU1674673691.USD","BK0224","BK4526","LU2471134523.USD","LU1551013425.SGD","BK4585","LU2471134796.USD","LU0097036916.USD","TSLI","LU0056508442.USD","UFO","IE00B19Z8W00.USD","LU1914381329.SGD","BK4533","TSLO","IE00BWXC8680.SGD","LU1778281490.HKD","BK4511","TSDD","IE00BK4W5L77.USD","LU2750360641.GBP","TSLY","LU0823414478.USD","LU0820561909.HKD","LU1066051225.USD","BK4592","LU0234572021.USD","IE00BSNM7G36.USD","TSLR","IE00B1BXHZ80.USD","LU1145028129.USD","BK1141"],"gpt_icon":0},{"id":"2608921332","title":"晶泰科技砸下重金入股Mirxes！解锁癌症早筛与精准治疗新可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2608921332","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608921332?lang=zh_cn&edition=full","pubTime":"2026-02-04 14:12","pubTimestamp":1770185537,"startTime":"0","endTime":"0","summary":"晶泰科技宣布以战略投资者身份，参与Mirxes（觅瑞）的新股配售，并将在中国和新加坡联合成立合资公司，共同发起“胃癌逐渐消除计划”。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3764723","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1617","02228","02629","BK1141","BK1161"],"gpt_icon":0},{"id":"2608637418","title":"每日卖空追踪 | 晶泰控股 02月02日卖空量成交346.2万股，卖空比例为5.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608637418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608637418?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021028,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间02月02日，跌4.64%，卖空量成交346.2万股，较上一交易日减少11.21%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163604a6c9850f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163604a6c9850f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2607048040","title":"安科生物：公司正积极与英硅智能、晶泰科技、元构生物等公司对接，推动AI在小分子、多肽、大分子蛋白质药物的靶点筛选，分子发现、结构优化等环节的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2607048040","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607048040?lang=zh_cn&edition=full","pubTime":"2026-01-30 20:53","pubTimestamp":1769777603,"startTime":"0","endTime":"0","summary":"证券之星消息，安科生物(300009)01月30日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司有没有利用AI的在研药物，或者已经进入临床的药物。如果有，请问有那些药物。安科生物回复：您好，公司正积极与英硅智能、晶泰科技、元构生物等公司对接，推动AI在小分子、多肽、大分子蛋白质药物的靶点筛选，分子发现、结构优化等环节的应用。谢谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000043737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0070","02228","BK1141","BK0042","BK1617","300009"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":-0.0658},{"period":"1month","weight":-0.1679},{"period":"3month","weight":0.051},{"period":"6month","weight":0.0194},{"period":"1year","weight":0.3509},{"period":"ytd","weight":0.111}],"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0},{"period":"3month","weight":0.0316},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.162},{"period":"ytd","weight":0.0443}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}